Analgesia pp 375-393

Part of the Methods in Molecular Biology book series (MIMB, volume 617)

Assessing Potential Functionality of Catechol-O-methyltransferase (COMT) Polymorphisms Associated with Pain Sensitivity and Temporomandibular Joint Disorders

Protocol

Abstract

Catechol-O-methyltransferase (COMT) is an enzyme that plays a key role in the modulation of catechol-dependent functions such as cognition, cardiovascular function, and pain processing. Recently, our group demonstrated that three common haplotypes of the human COMT gene, divergent in two synonymous and one nonsynonymous position, are associated with experimental pain sensitivity and onset of temporomandibular joint disorder. In order to determine the functional mechanisms whereby these haplotypes contribute to pain processing, a series of in vitro experiments were performed. Haplotypes divergent in synonymous changes exhibited the largest difference in COMT enzymatic activity because of reduced amount of translated protein. The major COMT haplotypes varied significantly with respect to mRNA local stem-loop structures such that the most stable structure was associated with the lowest protein levels and enzymatic activity. Site-directed mutagenesis that eliminated the stable structure restored the amount of translated protein. These data provide the first demonstration that combinations of commonly observed alleles in the coding region of the human COMT gene can significantly affect the secondary structure of corresponding mRNA transcripts, which in turn leads to dramatic alterations in the translation efficiency of enzyme crucial for a variety of essential functions. The protocols applied to the study of these molecular genetic mechanisms are detailed herein.

Key words

COMT Catecholamine Pain mRNA secondary structure Synonymous polymorphism Haplotype 

References

  1. 1.
    Mannisto PT, Kaakkola S (1999) Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 51:593–628PubMedGoogle Scholar
  2. 2.
    Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I, Goldman D, Xu K, Shabalina SA, Shagin D et al (2005) Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 14:135–143PubMedCrossRefGoogle Scholar
  3. 3.
    Marbach JJ, Levitt M (1976) Erythrocyte catechol-O-methyltransferase activity in facial pain patients. J Dent Res 55:711PubMedCrossRefGoogle Scholar
  4. 4.
    Rakvag TT, Klepstad P, Baar C, Kvam TM, Dale O, Kaasa S, Krokan HE, Skorpen F (2005) The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain 116:73–78PubMedCrossRefGoogle Scholar
  5. 5.
    Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D (2003) COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299:1240–1243PubMedCrossRefGoogle Scholar
  6. 6.
    Yampolsky LY, Kondrashov FA, Kondrashov AS (2005) Distribution of the strength of selection against amino acid replacements in human proteins. Hum Mol Genet 14:3191–3201PubMedCrossRefGoogle Scholar
  7. 7.
    Knight JC (2005) Regulatory polymorphisms underlying complex disease traits. J Mol Med 83:97–109PubMedCrossRefGoogle Scholar
  8. 8.
    Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, Maixner W, Diatchenko L (2006) Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314:1930–1933PubMedCrossRefGoogle Scholar
  9. 9.
    Lennon G, Auffray C, Polymeropoulos M, Soares MB (1996) The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics 33:151–152PubMedCrossRefGoogle Scholar
  10. 10.
    Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, Wagner L, Shenmen CM, Schuler GD, Altschul SF et al (2002) Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A 99:16899–16903PubMedCrossRefGoogle Scholar
  11. 11.
    Masuda M, Tsunoda M, Yusa Y, Yamada S, Imai K (2002) Assay of catechol-O-methyltransferase activity in human erythrocytes using nore­pinephrine as a natural substrate. Ann Clin Biochem 39:589–594PubMedCrossRefGoogle Scholar
  12. 12.
    Harrison GP, Mayo MS, Hunter E, Lever AM (1998) Pausing of reverse transcriptase on retroviral RNA templates is influenced by secondary structures both 5′ and 3′ of the catalytic site. Nucleic Acids Res 26:3433–3442PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Center for Neurosensory DisordersUniversity of North CarolinaChapel HillUSA
  2. 2.Center for Neurosensory Disorders, Carolina Center for Genome Sciences, University of North CarolinaChapel HillUSA

Personalised recommendations